Immune checkpoint markers, including expression of CTLA-4, TIM3, and Ox40 on CD8+ and CD4+ T cells were examined in the tumor draining lymph node and spleen (Supplementary Fig. 1 and Supplementary Fig. 2). This evidence concerns the gene HAVCR2 and neoplasm.